Skip to main content
SpringerLink
Log in

PPIs linked with increased risk of kidney disease

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Medicines containing esomeprazole, lansoprazole, omeprazole, pantoprazole or rabeprazole were counted as PPIs.

Reference

  • Hart E, et al. Proton pump inhibitors and risk of acute and chronic kidney disease: a retrospective cohort study. Pharmacotherapy : [23 pages], 18 Feb 2019. Available from: URL: http://dx.doi.org/10.1002/phar.2235

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

PPIs linked with increased risk of kidney disease. Reactions Weekly 1742, 11 (2019). https://doi.org/10.1007/s40278-019-58469-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-58469-8

Search

Navigation